Subscribe

Amgen Inc. (AMGN)

USD360.45 -2.94 (-0.81%)
US NASDAQ DJIA S&P 500 NASDAQ 100 Healthcare Drug Manufacturers - General
Address One Amgen Center Drive 91320-1799
Thousand Oaks, CA, US
CEO Robert A. Bradway
Website amgen.com
IPO 1983-06-17
CIK 318154 ISIN US0311621009

Explore sections of this company profile

Also trades on Deutsche Börse · AMG.DE (EUR) NASDAQ Global Select · AMGN (USD)
Description

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Additionally, Amgen maintains research and development partnerships with Neumora Therapeutics, Inc. and Plexium, Inc.

News Sentiment (7d)
53 Neutral

3 articles

Market Cap & Enterprise Value
Merger & Acquisition History
Target company Ticker Date Filing
Kinetix — 2000-11-03 View
Immunex — 2002-01-31 View
Tularik TLRK 2004-04-23 View

Index membership

IndexAddedRemovedStatus
DJIA 2020-08-31 — Active
S&P 500 1991-12-31 — Active
NASDAQ 100 1989-01-31 — Active
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD360.45 -2.94 (-0.81%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.40
Float Shares
538.47M
Free Float %
99.8%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+2.03% +2.07% -3.87% -8.91% +0.09% +2.74% +24.34% +44.00% +33.41% +120.74% +97,729.82%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (38 ratings, all time) Buy
Price Targets & DCF
Current price
360.45
Low 185.00 -48.7%
Consensus 352.31 -2.3%
Median 357.50 -0.8%
High 432.00 +19.9%
DCF (Unlevered) 1,066.11 +195.8%
DCF (Levered) 896.65 +148.8%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 37% Bullish
Rating 2026-05 Change
Strong Buy 4 0
Buy 9 0
Hold 19 0
Sell 2 0
Strong Sell 1 0
Price Target Summary
Period # Analysts Avg Target
Last Month 3
346.00
-4.0%
Last Quarter 11
339.73
-5.7%
Last Year 27
346.78
-3.8%
All Time 83
303.78
-15.7%
Quality scores
Altman Z-Score
2.28
Grey zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Drug Manufacturers - General: +6.6%
    +9.9% ★ Q1'26: +5.8% (vs Q1'25)
  • ✓
    EPS growth Drug Manufacturers - General: +18.2%
    +88.2% ★ Q1'26: +4.4% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Drug Manufacturers - General: +36.0%
    +21.7% Q1'26: +17.1% (vs Q1'25)
  • ✓
    EBIT margin Drug Manufacturers - General: +19.4%
    +29.1% ★ Q1'26: +31.8% (vs Q1'25)
  • ✓
    ROIC Drug Manufacturers - General: +10.2%
    +16.9% ★ Q1'26: +17.6% (vs Q1'25)
  • ✗
    Share dilution Drug Manufacturers - General: +0.0%
    +0.2% Q1'26: +0.6% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - General: -0.29×
    3.45× Q1'26: 5.23× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.44) × ERP
WACC = 77% × Ke + 23% × Kd (5.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 1,049.86 Current price: 360.45
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2011
actual 		Dec 2012
actual 		Dec 2013
actual 		Dec 2014
actual 		Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
25 Rev. Ana.
21 EPS Ana. 		Dec 2027
25 Rev. Ana.
21 EPS Ana. 		Dec 2028
27 Rev. Ana.
12 EPS Ana. 		Dec 2029
13 Rev. Ana.
10 EPS Ana. 		Dec 2030
13 Rev. Ana.
5 EPS Ana.
Revenue
15.58B
est: 14.91B (+4.5%)
17.27B
est: 15.57B (+10.9%)
18.68B
est: 17.24B (+8.3%)
20.06B
est: 18.89B (+6.2%)
21.66B
est: 21.64B (+0.1%)
22.99B
est: 22.79B (+0.9%)
22.85B
est: 22.90B (-0.2%)
23.75B
est: 23.37B (+1.6%)
23.36B
est: 23.19B (+0.8%)
25.42B
est: 25.36B (+0.2%)
25.98B
est: 26.00B (-0.1%)
26.32B
est: 26.17B (+0.6%)
28.19B
est: 30.93B (-8.9%)
33.42B
est: 33.20B (+0.7%)
36.74B
est: 36.36B (+1.1%)
37.78B
37.46B – 38.31B
+3.9% YoY
38.78B
37.68B – 40.00B
+2.7% YoY
39.77B
39.73B – 39.81B
+2.6% YoY
41.16B
40.10B – 42.72B
+3.5% YoY
42.76B
41.66B – 44.38B
+3.9% YoY
EBITDA
5.82B
est: 5.57B (+4.5%)
7.15B
est: 6.30B (+13.5%)
7.57B
est: 6.94B (+9.1%)
8.75B
est: 8.15B (+7.4%)
11.18B
est: 9.73B (+14.9%)
12.53B
est: 11.68B (+7.2%)
12.86B
est: 12.49B (+2.9%)
12.88B
est: 12.01B (+7.3%)
12.63B
est: 11.94B (+5.8%)
13.00B
est: 11.40B (+14.0%)
11.30B
est: 10.92B (+3.4%)
12.17B
est: 11.94B (+1.9%)
14.80B
est: 13.94B (+6.2%)
13.36B
est: 14.96B (-10.7%)
15.84B
est: 16.38B (-3.3%)
17.02B
16.88B – 17.26B
+3.9% YoY
17.48B
16.98B – 18.02B
+2.7% YoY
17.92B
17.90B – 17.94B
+2.6% YoY
18.55B
18.07B – 19.25B
+3.5% YoY
19.27B
18.77B – 20.00B
+3.9% YoY
EBIT
4.76B
est: 4.13B (+15.2%)
6.06B
est: 4.91B (+23.6%)
6.29B
est: 5.38B (+16.9%)
6.66B
est: 5.75B (+15.7%)
9.07B
est: 7.37B (+23.2%)
10.42B
est: 9.13B (+14.1%)
10.90B
est: 9.68B (+12.6%)
10.94B
est: 9.57B (+14.3%)
10.43B
est: 9.14B (+14.1%)
9.40B
est: 8.02B (+17.2%)
7.90B
est: 7.40B (+6.8%)
8.75B
est: 9.20B (-4.8%)
10.73B
est: 9.53B (+12.6%)
7.76B
est: 10.22B (-24.1%)
10.68B
est: 11.20B (-4.7%)
11.64B
11.54B – 11.80B
+3.9% YoY
11.95B
11.60B – 12.32B
+2.7% YoY
12.25B
12.24B – 12.26B
+2.6% YoY
12.68B
12.35B – 13.16B
+3.5% YoY
13.17B
12.83B – 13.67B
+3.9% YoY
Net Income
3.68B
est: 3.53B (+4.5%)
4.35B
est: 3.81B (+13.9%)
5.08B
est: 4.66B (+9.0%)
5.16B
est: 4.79B (+7.7%)
6.94B
est: 6.03B (+15.0%)
7.72B
est: 7.20B (+7.3%)
1.98B
est: 1.46B (+35.2%)
8.39B
est: 7.82B (+7.3%)
7.84B
est: 7.41B (+5.8%)
7.26B
est: 6.37B (+14.0%)
5.89B
est: 5.71B (+3.3%)
6.55B
est: 6.49B (+0.9%)
6.72B
est: 3.13B (+114.6%)
4.09B
est: 10.60B (-61.4%)
7.71B
est: 11.70B (-34.1%)
11.90B
11.22B – 12.58B
+1.7% YoY
12.50B
11.55B – 13.44B
+5.0% YoY
13.49B
10.38B – 16.61B
+8.0% YoY
14.07B
13.60B – 14.77B
+4.3% YoY
14.96B
14.46B – 15.69B
+6.3% YoY
SGA
4.50B
est: 4.28B (+5.1%)
4.81B
est: 4.28B (+12.5%)
5.18B
est: 4.75B (+9.1%)
4.70B
est: 4.39B (+7.0%)
4.85B
est: 4.22B (+14.9%)
5.06B
est: 4.73B (+7.1%)
4.87B
est: 4.76B (+2.3%)
5.33B
est: 4.98B (+7.1%)
5.15B
est: 4.87B (+5.7%)
5.73B
est: 5.03B (+14.0%)
5.37B
est: 5.18B (+3.7%)
5.41B
est: 5.20B (+4.1%)
6.18B
est: 6.41B (-3.6%)
7.10B
est: 6.88B (+3.2%)
7.05B
est: 7.53B (-6.4%)
7.83B
7.76B – 7.94B
+3.9% YoY
8.03B
7.80B – 8.29B
+2.7% YoY
8.24B
8.23B – 8.25B
+2.6% YoY
8.53B
8.31B – 8.85B
+3.5% YoY
8.86B
8.63B – 9.19B
+3.9% YoY
EPS
4.07
est: 4.84 (-15.9%)
5.61
est: 5.17 (+8.5%)
6.75
est: 6.45 (+4.7%)
6.80
est: 7.64 (-11.0%)
9.15
est: 10.08 (-9.3%)
10.32
est: 11.56 (-10.7%)
2.71
est: 12.70 (-78.7%)
12.70
est: 14.27 (-11.0%)
12.96
est: 14.60 (-11.2%)
12.40
est: 16.08 (-22.9%)
10.34
est: 16.82 (-38.5%)
12.18
est: 17.68 (-31.1%)
12.56
est: 5.83 (+115.3%)
7.62
est: 19.61 (-61.1%)
14.33
est: 21.32 (-32.8%)
22.40
20.71 – 23.21
+5.1% YoY
23.45
21.32 – 24.80
+4.7% YoY
24.51
19.15 – 30.64
+4.5% YoY
25.97
25.10 – 27.25
+5.9% YoY
27.59
26.67 – 28.95
+6.3% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-05-04 Guggenheim Neutral Neutral Maintain
2026-05-01 Truist Securities Hold Hold Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-05-11 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-05-08 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-05-07 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-05-06 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-05-05 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-05-04 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-05-01 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-04-30 A- 4/5 5/5 5/5 5/5 1/5 3/5 1/5
2026-04-29 A- 4/5 5/5 5/5 5/5 1/5 3/5 1/5
2026-04-28 A- 4/5 5/5 5/5 5/5 1/5 3/5 1/5
2026-04-27 A- 4/5 5/5 5/5 5/5 1/5 3/5 1/5
2026-04-24 A- 4/5 5/5 5/5 5/5 1/5 3/5 1/5
2026-04-23 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-04-22 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-04-21 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-04-20 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-04-17 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-04-16 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5
2026-04-15 B+ 3/5 5/5 5/5 5/5 1/5 2/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
9.23B
OE per share TTM
17.04
Owner's Yield
5.08%
Maintenance CapEx ratio
33.86%
Maint CapEx / Avg PPE
20.5%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
1,185
Total invested
6.80B
Insider transactions (90d)
0
Beneficial owners (>5%)
26
Beneficial owners (>5%)
# Reporting person ⇅ Amount owned ⇅ % of class ⇅ Sole voting ⇅ Shared voting ⇅ Sole dispositive ⇅ Shared dispositive ⇅ Type Citizenship Filing date ⇅ SEC filing
1 MDP Holdings, Inc. ("MDP") 98.29M 7.70% — 98.29M — 98.29M CO Delaware 2002-07-23 ↗
2 Wyeth 98.29M 7.70% — 98.29M — 98.29M CO Delaware 2002-07-23 ↗
3 BlackRock for purposes of Schedule 13G filings. 68.59M 6.76% 68.59M — 68.59M — HC Delaware 2010-01-29 ↗
4 Abigail P. Johnson 54.50M 5.33% — — 54.50M — IN United States of America 2000-02-11 ↗
5 FMR Corp. 54.50M 5.33% 4.64M — 54.50M — HC Commonwealth of Massachusetts 2000-02-11 ↗
6 943112180 49.78M 4.27% 41.66M — 49.78M — BK U.S.A. 2007-01-23 ↗
7 Edward C. Johnson 3d 43.95M 5.01% — — 43.95M — IN United States of America 2012-02-14 ↗
8 Amgen Inc. 35.37M 23.20% 35.37M — 35.37M — CO — 2023-09-27 ↗
9 STATE STREET CORPORATION 30.22M 5.37% — 21.56M — 30.15M HC — 2022-02-10 ↗
10 BARCLAYS GLOBAL FUND ADVISORS 10.06M 0.86% 10.05M — 10.06M — IA U.S.A. 2007-01-23 ↗
11 BARCLAYS GLOBAL INVESTORS, LTD 7.24M 0.62% 7.24M — 7.24M — BK England 2007-01-23 ↗
12 AMGEN SINGAPORE MANUFACTURING PTE. LTD. 4.91M 6.00% — 4.91M — 4.91M CO Netherlands 2022-12-02 ↗
13 AMGEN TECHNOLOGY, LIMITED 4.91M 6.00% — 4.91M — 4.91M CO Netherlands 2022-12-02 ↗
14 ONYX PHARMACEUTICALS, INC. 4.91M 6.00% — 4.91M — — CO Netherlands 2022-12-02 ↗
15 SAGA INVESTMENTS COÖPERATIEF U.A. 4.91M 6.00% — 4.91M — 4.91M CO Netherlands 2022-12-02 ↗
16 10) 3.05M 7.60% 3.05M — 3.05M — CO Delaware 2017-02-07 ↗
17 95-3540776 2.50M 6.50% — — — — CO Delaware 2006-02-03 ↗
18 10. 2.50M 5.30% 2.50M — 2.50M — CO Delaware 2019-09-25 ↗
19 1,905,698 1.91M 6.67% 1.91M — — — CO Delaware 2020-02-10 ↗
20 BARCLAYS GLOBAL INVESTORS JAPAN LIMITED 1.63M 0.14% 1.63M — 1.63M — IA Japan 2007-01-23 ↗
21 6.0% (2) 1.47M 12.00% 615.4K 853.1K 615.4K 853.1K CO Delaware 2015-04-01 ↗
22 Amgen Inc.             95-3540776 1.45M 7.40% 1.45M — 1.45M — CO Citizenship or Place of Organization 2007-02-09 ↗
23 4.9% (2) 1.40M 4.90% 550.4K 853.1K 550.4K 853.1K CO Delaware 2017-02-07 ↗
24 BARCLAYS GLOBAL INVESTORS JAPAN TRUST AND BANKING COMPANY LIMITED 1.26M 0.11% 1.26M — 1.26M — BK Japan 2007-01-23 ↗
25 1,121,384 1.12M 5.90% — 1.12M — 1.12M CO Delaware 2019-02-08 ↗
26 SAMUEL R. SHAPIRO 20.0K 0.01% 24.00M — 24.00M — IN Delaware 2016-03-03 ↗

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
1,185
-1,978 vs prev Q
New positions
73
Closed positions
1,968
Increased
523
Reduced
480
Put/Call ratio
0.13
Calls held
20.1K
Puts held
2.6K
Top institutional holders
# Investor ⇅ Shares / Δ ⇅ Mkt value / Δ ⇅ Own% / Δ ⇅ Weight% / Δ ⇅ Avg px / Perf. ⇅ Hold / Status ⇅
1 VANGUARD GROUP INC 54.84M +962.0K (+1.8%) 17.95B +2.7B (+18.1%) 10.17% +0.160 pp 0.26% +0.033 pp USD126.81 +158.1% 84 qtrs —
2 BLACKROCK, INC. 47.40M +1.4M (+3.0%) 15.51B +2.5B (+19.4%) 8.79% +0.237 pp 0.26% +0.035 pp USD321.32 +1.9% 6 qtrs —
3 STATE STREET CORP 30.59M +1.3M (+4.4%) 10.01B +1.7B (+21.1%) 5.68% +0.229 pp 0.34% +0.049 pp USD157.21 +108.2% 51 qtrs —
4 CAPITAL WORLD INVESTORS 23.10M +4.3M (+22.9%) 7.56B +2.3B (+42.6%) 4.29% +0.792 pp 1.03% +0.304 pp USD298.73 +9.6% 6 qtrs —
5 CAPITAL INTERNATIONAL INVESTORS 18.19M -1.0M (-5.2%) 5.95B +538.7M (+9.9%) 3.37% -0.193 pp 0.93% +0.059 pp USD282.48 +15.9% 51 qtrs —
6 MORGAN STANLEY 15.74M -166.0K (-1.0%) 5.15B +663.4M (+14.8%) 2.92% -0.036 pp 0.31% +0.036 pp USD225.03 +45.5% 51 qtrs —
7 GEODE CAPITAL MANAGEMENT, LLC 14.30M +1.0M (+7.8%) 4.67B +936.3M (+25.1%) 2.65% +0.188 pp 0.29% +0.050 pp USD182.84 +79.0% 78 qtrs —
8 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11.81M -1.7M (-12.8%) 3.87B +41.9M (+1.1%) 2.19% -0.327 pp 0.60% -0.010 pp USD227.12 +44.1% 100 qtrs —
9 PRIMECAP MANAGEMENT CO/CA/ 8.90M -802.6K (-8.3%) 2.91B +175.2M (+6.4%) 1.65% -0.152 pp 2.21% +0.108 pp USD59.52 +449.9% 93 qtrs —
10 WELLS FARGO & COMPANY/MN 7.11M -46.7K (-0.7%) 2.33B +307.6M (+15.2%) 1.32% -0.011 pp 0.42% +0.040 pp USD176.63 +85.3% 57 qtrs —
11 NORGES BANK 6.61M +6.6M (+100.0%) 2.16B +2.2B (+100.0%) 1.23% +1.227 pp 0.23% +0.232 pp USD327.31 +0.0% 1 qtrs NEW
12 NORTHERN TRUST CORP 6.18M +37.2K (+0.6%) 2.02B +289.3M (+16.7%) 1.15% +0.005 pp 0.26% +0.036 pp USD140.80 +132.5% 51 qtrs —
13 BANK OF AMERICA CORP /DE/ 5.54M +351.7K (+6.8%) 1.81B +349.0M (+23.9%) 1.03% +0.064 pp 0.13% +0.033 pp USD281.02 +16.5% 52 qtrs —
14 INVESCO LTD. 4.79M +321.2K (+7.2%) 1.57B +306.6M (+24.3%) 0.89% +0.058 pp 0.24% +0.042 pp USD241.57 +35.5% 57 qtrs —
15 ROYAL BANK OF CANADA 4.70M +174.4K (+3.8%) 1.54B +261.4M (+20.4%) 0.87% +0.031 pp 0.25% +0.041 pp USD221.40 +47.8% 51 qtrs —
16 CAPITAL RESEARCH GLOBAL INVESTORS 4.65M -83.1K (-1.8%) 1.52B +186.2M (+13.9%) 0.86% -0.017 pp 0.28% +0.030 pp USD157.31 +108.1% 51 qtrs —
17 UBS ASSET MANAGEMENT AMERICAS INC 4.60M +54.7K (+1.2%) 1.51B +223.1M (+17.4%) 0.86% +0.010 pp 0.32% +0.040 pp USD264.83 +23.6% 90 qtrs —
18 GOLDMAN SACHS GROUP INC 4.53M +83.7K (+1.9%) 1.48B +228.0M (+18.2%) 0.84% +0.016 pp 0.18% +0.028 pp USD257.72 +27.0% 73 qtrs —
19 UBS GROUP AG 4.10M -128.2K (-3.0%) 1.34B +149.0M (+12.5%) 0.76% -0.025 pp 0.22% +0.031 pp USD237.53 +37.8% 45 qtrs —
20 BANK OF NEW YORK MELLON CORP 3.91M -72.2K (-1.8%) 1.28B +155.9M (+13.9%) 0.72% -0.015 pp 0.23% +0.010 pp USD136.85 +139.2% 66 qtrs —
21 LEGAL & GENERAL GROUP PLC 3.81M +94.5K (+2.5%) 1.25B +198.6M (+18.9%) 0.71% +0.016 pp 0.28% +0.041 pp USD150.55 +117.4% 75 qtrs —
22 FMR LLC 3.59M +188.1K (+5.5%) 1.18B +215.1M (+22.4%) 0.67% +0.034 pp 0.06% +0.010 pp USD207.11 +58.0% 70 qtrs —
23 AMUNDI 3.40M +988.9K (+41.1%) 1.11B +403.6M (+57.0%) 0.63% +0.184 pp 0.30% +0.075 pp USD273.45 +19.7% 19 qtrs —
24 ARISTOTLE CAPITAL MANAGEMENT, LLC 3.29M -181.9K (-5.2%) 1.08B +97.2M (+9.9%) 0.61% -0.034 pp 2.16% +0.263 pp USD200.17 +63.5% 40 qtrs —
25 DIMENSIONAL FUND ADVISORS LP 3.23M +52.4K (+1.6%) 1.06B +160.7M (+17.9%) 0.60% +0.010 pp 0.22% +0.029 pp USD186.06 +75.9% 51 qtrs —
26 STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 2.72M +— (+0.0%) 888.86M +122.5M (+16.0%) 0.50% -0.001 pp 0.70% +0.059 pp USD68.74 +376.2% 108 qtrs —
27 NORDEA INVESTMENT MANAGEMENT AB 2.60M -273.3K (-9.5%) 851.92M +57.5M (+7.2%) 0.48% -0.051 pp 0.73% +0.036 pp USD237.25 +38.0% 88 qtrs —
28 JANUS HENDERSON GROUP PLC 2.32M -321.8K (-12.2%) 760.30M +14.0M (+1.9%) 0.43% -0.061 pp 0.34% 0.000 pp USD291.04 +12.5% 88 qtrs —
29 JPMORGAN CHASE & CO 2.29M -1.9M (-45.8%) 750.73M -443.0M (-37.1%) 0.43% -0.360 pp 0.05% -0.024 pp USD265.98 +23.1% 51 qtrs —
30 DEUTSCHE BANK AG\ 2.19M -447.4K (-17.0%) 717.07M -27.4M (-3.7%) 0.41% -0.083 pp 0.23% -0.016 pp USD211.45 +54.8% 50 qtrs —
31 FRANKLIN RESOURCES INC 2.18M -466.5K (-17.7%) 712.09M -33.5M (-4.5%) 0.40% -0.088 pp 0.17% -0.011 pp USD244.84 +33.7% 51 qtrs —
32 CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 2.09M -4.7K (-0.2%) 683.29M +92.9M (+15.7%) 0.39% -0.001 pp 0.39% +0.037 pp USD199.87 +63.8% 58 qtrs —
33 AMERIPRISE FINANCIAL INC 2.03M +26.3K (+1.3%) 664.12M +100.3M (+17.8%) 0.38% +0.004 pp 0.15% +0.021 pp USD216.16 +51.4% 55 qtrs —
34 NUVEEN, LLC 1.97M -86.3K (-4.2%) 643.46M +64.3M (+11.1%) 0.36% -0.017 pp 0.17% +0.016 pp USD311.55 +5.1% 4 qtrs —
35 BARCLAYS PLC 1.92M -401.4K (-17.3%) 628.60M -119.5M (-16.0%) 0.36% -0.075 pp 0.15% -0.041 pp USD284.08 +15.2% 51 qtrs —
36 FEDERATED HERMES, INC. 1.80M -288.1K (-13.8%) 588.97M -133.1K (0.0%) 0.33% -0.054 pp 0.98% -0.056 pp USD262.63 +24.6% 54 qtrs —
37 RAYMOND JAMES FINANCIAL INC 1.70M -43.8K (-2.5%) 557.34M +64.5M (+13.1%) 0.32% -0.009 pp 0.17% +0.015 pp USD265.34 +23.4% 5 qtrs —
38 SUMITOMO MITSUI TRUST HOLDINGS, INC. 1.61M -43.7K (-2.6%) 527.74M +60.4M (+12.9%) 0.30% -0.008 pp 0.31% +0.041 pp USD148.39 +120.6% 59 qtrs —
39 STIFEL FINANCIAL CORP 1.59M +53.9K (+3.5%) 521.90M +87.1M (+20.0%) 0.30% +0.010 pp 0.47% +0.073 pp USD235.75 +38.8% 48 qtrs —
40 HSBC HOLDINGS PLC 1.54M +110.4K (+7.7%) 503.57M +101.6M (+25.3%) 0.29% +0.021 pp 0.26% +0.035 pp USD258.06 +26.8% 56 qtrs —
41 SWISS NATIONAL BANK 1.48M -74.7K (-4.8%) 482.87M +45.5M (+10.4%) 0.27% -0.014 pp 0.29% +0.034 pp USD176.14 +85.8% 51 qtrs —
42 CAPITAL WEALTH PLANNING, LLC 1.45M +621.4K (+75.2%) 473.87M +240.8M (+103.3%) 0.27% +0.115 pp 3.07% +1.425 pp USD307.41 +6.5% 32 qtrs —
43 SUSQUEHANNA INTERNATIONAL GROUP, LLP 1.41M +264.7K (+23.0%) 463.08M +138.5M (+42.7%) 0.26% +0.049 pp 0.05% +0.016 pp USD280.04 +16.9% 51 qtrs —
44 MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 1.30M +57.6K (+4.7%) 424.35M +75.1M (+21.5%) 0.24% +0.011 pp 0.29% +0.036 pp USD264.99 +23.5% 58 qtrs —
45 PACER ADVISORS, INC. 1.26M -355.9K (-22.1%) 411.50M -43.7M (-9.6%) 0.23% -0.066 pp 1.05% -0.095 pp USD305.52 +7.1% 41 qtrs —
46 NATIONAL PENSION SERVICE 1.24M +55.5K (+4.7%) 405.72M +71.6M (+21.4%) 0.23% +0.010 pp 0.30% +0.041 pp USD216.30 +51.3% 46 qtrs —
47 ENVESTNET ASSET MANAGEMENT INC 1.20M -101.5K (-7.8%) 392.01M +25.4M (+6.9%) 0.22% -0.019 pp 0.12% +0.011 pp USD256.10 +27.8% 51 qtrs —
48 MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.19M +260.5K (+28.0%) 390.25M +127.3M (+48.4%) 0.22% +0.048 pp 0.32% +0.105 pp USD273.98 +19.5% 108 qtrs —
49 LPL FINANCIAL LLC 1.18M +41.2K (+3.6%) 387.26M +65.0M (+20.2%) 0.22% +0.007 pp 0.11% +0.012 pp USD248.28 +31.8% 51 qtrs —
50 BEUTEL, GOODMAN & CO LTD. 1.18M -264.5K (-18.3%) 387.03M -21.3M (-5.2%) 0.22% -0.050 pp 2.38% -0.082 pp USD237.04 +38.1% 31 qtrs —
51 VICTORY CAPITAL MANAGEMENT INC 1.14M +475.8K (+71.9%) 372.25M +185.6M (+99.4%) 0.21% +0.088 pp 0.21% +0.101 pp USD270.68 +20.9% 43 qtrs —
52 BNP PARIBAS ARBITRAGE, SNC 1.12M +378.3K (+51.0%) 366.56M +157.3M (+75.1%) 0.21% +0.070 pp 0.17% +0.054 pp USD297.98 +9.8% 51 qtrs —
53 BANK OF MONTREAL /CAN/ 1.08M +20.7K (+2.0%) 354.74M +54.7M (+18.2%) 0.20% +0.004 pp 0.12% +0.008 pp USD252.74 +29.5% 51 qtrs —
54 PROSHARE ADVISORS LLC 1.07M +283.3K (+35.9%) 351.24M +128.3M (+57.6%) 0.20% +0.053 pp 0.62% +0.153 pp USD264.64 +23.7% 77 qtrs —
55 MARINER, LLC 1.07M +18.2K (+1.7%) 350.68M +53.5M (+18.0%) 0.20% +0.003 pp 0.42% +0.034 pp USD253.97 +28.9% 50 qtrs —
56 PNC FINANCIAL SERVICES GROUP, INC. 1.05M -66.3K (-5.9%) 343.34M +28.6M (+9.1%) 0.19% -0.013 pp 0.19% -0.003 pp USD142.39 +129.9% 51 qtrs —
57 PRICE T ROWE ASSOCIATES INC /MD/ 1.04M -11.8K (-1.1%) 341.63M +43.7M (+14.7%) 0.19% -0.002 pp 0.04% +0.005 pp USD258.21 +26.8% 75 qtrs —
58 RHUMBLINE ADVISERS 931.1K -27.1K (-2.8%) 304.75M +34.4M (+12.7%) 0.17% -0.005 pp 0.25% +0.029 pp USD128.09 +155.5% 56 qtrs —
59 BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 925.0K +732.3K (+380.0%) 302.83M +248.9M (+461.6%) 0.17% +0.136 pp 0.35% +0.208 pp USD320.16 +2.2% 51 qtrs —
60 FISHER ASSET MANAGEMENT, LLC 903.6K +118.3K (+15.1%) 295.74M +74.1M (+33.5%) 0.17% +0.022 pp 0.10% +0.021 pp USD275.25 +18.9% 57 qtrs —
61 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 845.1K -16.9K (-2.0%) 276.60M +33.3M (+13.7%) 0.16% -0.003 pp 0.28% +0.027 pp USD142.21 +130.2% 52 qtrs —
62 CITADEL ADVISORS LLC 818.0K -493.4K (-37.6%) 267.74M -102.3M (-27.7%) 0.15% -0.092 pp 0.04% -0.016 pp USD259.80 +26.0% 38 qtrs —
63 VAN ECK ASSOCIATES CORP 817.8K -540.3K (-39.8%) 267.69M -115.6M (-30.2%) 0.15% -0.101 pp 0.22% -0.135 pp USD264.18 +23.9% 57 qtrs —
64 SMEAD CAPITAL MANAGEMENT, INC. 801.8K -55.6K (-6.5%) 262.44M +20.5M (+8.5%) 0.15% -0.010 pp 5.45% +0.772 pp USD217.00 +50.8% 51 qtrs —
65 HIGHTOWER ADVISORS, LLC 786.6K -2.8K (-0.3%) 257.47M +34.7M (+15.6%) 0.15% -0.001 pp 0.28% +0.029 pp USD236.53 +38.4% 67 qtrs —
66 CITIGROUP INC 783.7K -23.9K (-3.0%) 256.51M +28.6M (+12.6%) 0.15% -0.005 pp 0.11% +0.012 pp USD249.61 +31.1% 108 qtrs —
67 TWO SIGMA ADVISERS, LP 735.9K +674.7K (+1,102.4%) 240.86M +223.6M (+1,294.6%) 0.14% +0.125 pp 0.47% +0.434 pp USD323.49 +1.2% 49 qtrs —
68 BOSTON PARTNERS 724.8K +1.1K (+0.1%) 237.22M +32.8M (+16.0%) 0.13% +0.000 pp 0.25% +0.036 pp USD246.49 +32.8% 76 qtrs —
69 TWO SIGMA INVESTMENTS, LP 700.4K +624.0K (+816.4%) 229.24M +207.7M (+962.9%) 0.13% +0.116 pp 0.32% +0.291 pp USD322.35 +1.5% 49 qtrs —
70 NATIONAL BANK OF CANADA /FI/ 676.0K -550.4K (-44.9%) 221.24M -124.8M (-36.1%) 0.13% -0.103 pp 0.20% -0.143 pp USD276.44 +18.4% 17 qtrs —
71 PICTET ASSET MANAGEMENT HOLDING SA 673.7K +32.6K (+5.1%) 221.02M +41.7M (+23.3%) 0.13% +0.006 pp 0.21% +0.042 pp USD284.61 +15.0% 10 qtrs —
72 US BANCORP \DE\ 668.1K -19.4K (-2.8%) 218.67M +24.7M (+12.7%) 0.12% -0.004 pp 0.26% +0.026 pp USD151.21 +116.5% 51 qtrs —
73 PRUDENTIAL FINANCIAL INC 663.0K -12.7K (-1.9%) 216.99M +26.3M (+13.8%) 0.12% -0.003 pp 0.26% +0.035 pp USD261.27 +25.3% 85 qtrs —
74 DEKABANK DEUTSCHE GIROZENTRALE 711.6K +— (+0.0%) 215.27M +20.4M (+10.5%) 0.13% 0.000 pp 0.37% +0.044 pp USD221.78 +47.6% 66 qtrs —
75 SARASIN & PARTNERS LLP 655.5K -4.5K (-0.7%) 214.56M +33.7M (+18.7%) 0.12% -0.001 pp 2.23% +0.453 pp USD198.29 +65.1% 51 qtrs —
76 JANE STREET GROUP, LLC 647.2K -74.0K (-10.3%) 211.84M +8.3M (+4.1%) 0.12% -0.014 pp 0.03% +0.001 pp USD291.59 +12.3% 6 qtrs —
77 ROCKEFELLER CAPITAL MANAGEMENT L.P. 642.2K +138.6K (+27.5%) 210.19M +68.1M (+47.9%) 0.12% +0.026 pp 0.38% +0.101 pp USD276.62 +18.3% 32 qtrs —
78 ABRDN PLC 629.6K +27.1K (+4.5%) 206.09M +39.3M (+23.5%) 0.12% +0.005 pp 0.32% +0.055 pp USD262.94 +24.5% 34 qtrs —
79 CANADA PENSION PLAN INVESTMENT BOARD 626.9K -154.2K (-19.7%) 205.21M -15.2M (-6.9%) 0.12% -0.029 pp 0.14% -0.018 pp USD285.70 +14.6% 52 qtrs —
80 NEW YORK STATE COMMON RETIREMENT FUND 619.2K -6.0K (-1.0%) 202.66M +26.2M (+14.9%) 0.11% -0.001 pp 0.27% +0.042 pp USD64.46 +407.8% 103 qtrs —
81 PRINCIPAL FINANCIAL GROUP INC 611.4K +18.8K (+3.2%) 200.10M +32.9M (+19.7%) 0.11% +0.004 pp 0.10% +0.018 pp USD148.43 +120.5% 81 qtrs —
82 ALLIANCEBERNSTEIN L.P. 585.2K -9.6K (-1.6%) 191.55M +23.7M (+14.1%) 0.11% -0.002 pp 0.06% +0.008 pp USD179.94 +81.9% 61 qtrs —
83 KBC GROUP NV 572.1K +86.7K (+17.9%) 187.27M +50.3M (+36.7%) 0.11% +0.016 pp 0.43% +0.099 pp USD286.25 +14.3% 68 qtrs —
84 MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 570.4K -21.5K (-3.6%) 186.70M +19.7M (+11.8%) 0.11% -0.004 pp 0.52% -0.006 pp USD253.73 +29.0% 57 qtrs —
85 THRIVENT FINANCIAL FOR LUTHERANS 546.0K -6.6K (-1.2%) 178.75M +22.8M (+14.6%) 0.10% -0.001 pp 0.32% +0.010 pp USD259.47 +26.1% 74 qtrs —
86 CI PRIVATE WEALTH, LLC 537.6K +188.5K (+54.0%) 176.00M +78.9M (+81.3%) 0.10% +0.035 pp 0.24% +0.084 pp USD274.83 +19.1% 13 qtrs —
87 KING LUTHER CAPITAL MANAGEMENT CORP 515.7K +6.5K (+1.3%) 168.78M +25.1M (+17.5%) 0.10% +0.001 pp 0.69% +0.095 pp USD125.94 +159.9% 52 qtrs —
88 SCHRODER INVESTMENT MANAGEMENT GROUP 507.9K +174.3K (+52.3%) 166.93M +75.6M (+82.7%) 0.09% +0.032 pp 0.13% +0.057 pp USD247.49 +32.3% 51 qtrs —
89 CAPTRUST FINANCIAL ADVISORS 498.3K +12.6K (+2.6%) 163.09M +26.0M (+19.0%) 0.09% +0.002 pp 0.31% +0.031 pp USD257.57 +27.1% 35 qtrs —
90 MIZUHO MARKETS CAYMAN LP 489.8K -700.0 (-0.1%) 160.31M +21.9M (+15.8%) 0.09% 0.000 pp 8.09% -0.387 pp USD279.24 +17.2% 3 qtrs —
91 FIRST TRUST ADVISORS LP 484.2K -4.6K (-0.9%) 158.48M +20.5M (+14.9%) 0.09% -0.001 pp 0.12% +0.013 pp USD240.64 +36.0% 51 qtrs —
92 ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. 481.5K +43.9K (+10.0%) 157.58M +34.1M (+27.6%) 0.09% +0.008 pp 0.22% +0.046 pp USD239.49 +36.7% 74 qtrs —
93 STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 473.5K -11.5K (-2.4%) 154.99M +18.1M (+13.2%) 0.09% -0.002 pp 0.27% +0.035 pp USD124.97 +161.9% 51 qtrs —
94 UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 465.5K +1.3K (+0.3%) 151.97M +21.0M (+16.0%) 0.09% +0.000 pp 0.25% +0.029 pp USD260.85 +25.5% 5 qtrs —
95 NEUBERGER BERMAN GROUP LLC 462.9K +318.8K (+221.4%) 151.52M +110.9M (+272.8%) 0.09% +0.059 pp 0.11% +0.083 pp USD319.78 +2.4% 51 qtrs —
96 M&G PLC 459.4K +4.8K (+1.1%) 150.22M +22.0M (+17.2%) 0.09% +0.001 pp 0.77% +0.090 pp USD296.51 +10.4% 8 qtrs —
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
1.63
Bullish
Ratio by volume
0.99
Neutral
Buys
13
Sells
8
Shares acquired
285.1K
Shares disposed
287.3K
Cash buys
—
Cash sales
2.00
Net activity
-2,204
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-16 Santos Esteban Officer F-InKind D Common Stock 5,621 366.21 2.06M 82,404 D ↗
2026-03-16 REESE DAVID M Officer F-InKind D Common Stock 6,022 366.21 2.21M 41,787 D ↗
2026-03-16 Miller Derek Officer F-InKind D Common Stock 1,616 366.21 591.8K 12,173 D ↗
2026-03-16 Khosla Rachna Officer F-InKind D Common Stock 707 366.21 258.9K 8,291 D ↗
2026-03-16 Grygiel Nancy A. Officer F-InKind D Common Stock 787 366.21 288.2K 8,488 D ↗
2026-03-16 Griffith Peter H. Officer F-InKind D Common Stock 5,748 366.21 2.10M 49,001 D ↗
2026-03-16 Graham Jonathan P Officer F-InKind D Common Stock 5,353 366.21 1.96M 39,267 D ↗
2026-03-16 Gordon Murdo Officer F-InKind D Common Stock 6,691 366.21 2.45M 50,292 D ↗
2026-03-16 Busch Matthew C. Officer F-InKind D Common Stock 327 366.21 119.8K 4,048 D ↗
2026-03-16 Bradway Robert A Director / Officer F-InKind D Common Stock 21,294 366.21 7.80M 501,862 D ↗
2026-03-04 Bradway Robert A Director / Officer M-Exempt A Common Stock 119,782 156.35 18.73M 576,928 D ↗
2026-03-03 Santos Esteban Officer A-Award A Common Stock 11,259 0.00 — 87,877 D ↗
2026-03-03 REESE DAVID M Officer A-Award A Common Stock 12,063 0.00 — 47,650 D ↗
2026-03-03 Miller Derek Officer A-Award A Common Stock 3,484 0.00 — 13,744 D ↗
2026-03-03 Khosla Rachna Officer A-Award A Common Stock 1,876 0.00 — 8,972 D ↗
2026-03-03 Grygiel Nancy A. Officer A-Award A Common Stock 2,010 0.00 — 9,249 D ↗
2026-03-03 Griffith Peter H. Officer A-Award A Common Stock 12,063 0.00 — 54,587 D ↗
2026-03-03 Graham Jonathan P Officer A-Award A Common Stock 10,723 0.00 — 44,478 D ↗
2026-03-03 Gordon Murdo Officer A-Award A Common Stock 13,403 0.00 — 56,807 D ↗
2026-03-03 Busch Matthew C. Officer A-Award A Common Stock 938 0.00 — 4,361 D ↗
2026-03-03 Bradway Robert A Director / Officer A-Award A Common Stock 42,657 0.00 — 457,146 D ↗
2026-02-26 Santos Esteban Officer M-Exempt A Common Stock 30,501 162.60 4.96M 107,119 D ↗
2026-02-19 Busch Matthew C. Officer S-Sale D Common Stock 1,000 375.79 375.8K 3,423 D ↗
2026-02-09 Bradner James E. Officer F-InKind D Common Stock 2,151 384.32 826.7K 28,331 D ↗
2025-11-20 Grygiel Nancy A. Officer S-Sale D Common Stock 1,639 337.26 552.8K 7,225 D ↗
2025-11-12 REESE DAVID M Officer G-Gift D Common Stock 309 0.00 — 35,503 D ↗
2025-11-12 Khosla Rachna Officer S-Sale D Common Stock 890 336.24 299.3K 7,082 D ↗
2025-11-12 Gordon Murdo Officer S-Sale D Common Stock 6,879 336.83 2.32M 41,923 D ↗
2025-11-11 REESE DAVID M Officer G-Gift D Common Stock 6,490 0.00 — 35,812 D ↗
2025-11-07 ISHRAK OMAR Director A-Award A Common Stock 219 0.00 — 6,508 D ↗
2025-11-07 HOLLEY CHARLES M Director A-Award A Common Stock 265 0.00 — 11,834 D ↗
2025-11-07 Drake Michael V Director A-Award A Common Stock 219 0.00 — 4,959 D ↗
2025-11-05 Khosla Rachna Officer F-InKind D Common Stock 226 296.70 67.1K 7,972 D ↗
2025-11-05 Busch Matthew C. Officer F-InKind D Common Stock 202 296.70 59.9K 4,414 D ↗
2025-08-20 Grygiel Nancy A. Officer S-Sale D Common Stock 1,267 296.99 376.3K 7,209 D ↗
2025-08-08 ISHRAK OMAR Director A-Award A Common Stock 121 0.00 — 6,242 D ↗
2025-08-08 HOLLEY CHARLES M Director A-Award A Common Stock 147 0.00 — 11,470 D ↗
2025-08-08 Drake Michael V Director A-Award A Common Stock 121 0.00 — 4,699 D ↗
2025-06-05 Khosla Rachna Officer S-Sale D Common Stock 1,500 289.68 434.5K 8,162 D ↗
2025-05-23 MILES AMY E Director A-Award A Common Stock 809 0.00 — 4,842 D ↗
2025-05-23 Kullman Ellen Jamison Director A-Award A Common Stock 809 0.00 — 13,467 D ↗
2025-05-23 Klotman Mary E. Director A-Award A Common Stock 809 0.00 — 1,528 D ↗
2025-05-23 Jacks Tyler Director A-Award A Common Stock 809 0.00 — 17,193 D ↗
2025-05-23 ISHRAK OMAR Director A-Award A Common Stock 809 0.00 — 6,084 D ↗
2025-05-23 HOLLEY CHARLES M Director A-Award A Common Stock 809 0.00 — 11,237 D ↗
2025-05-23 Garland Greg C. Director A-Award A Common Stock 809 0.00 — 13,183 D ↗
2025-05-23 ECKERT ROBERT Director A-Award A Common Stock 809 0.00 — 25,027 D ↗
2025-05-23 Druker Brian Director A-Award A Common Stock 809 0.00 — 7,569 D ↗
2025-05-23 Drake Michael V Director A-Award A Common Stock 809 0.00 — 4,547 D ↗
2025-05-23 Austin Wanda M Director A-Award A Common Stock 809 0.00 — 7,353 D ↗
2025-05-06 Santos Esteban Officer A-Award A Nqso (Right to Buy) 21,510 270.44 5.82M 21,510 D ↗
2025-05-06 REESE DAVID M Officer A-Award A Nqso (Right to Buy) 22,944 270.44 6.20M 22,944 D ↗
2025-05-06 Miller Derek Officer A-Award A Nqso (Right to Buy) 6,214 270.44 1.68M 6,214 D ↗
2025-05-06 Khosla Rachna Officer A-Award A Nqso (Right to Buy) 3,943 270.44 1.07M 3,943 D ↗
2025-05-06 ISHRAK OMAR Director A-Award A Common Stock 129 0.00 — 5,275 D ↗
2025-05-06 HOLLEY CHARLES M Director A-Award A Common Stock 157 0.00 — 10,428 D ↗
2025-05-06 Grygiel Nancy A. Officer A-Award A Common Stock 591 0.00 — 8,463 D ↗
2025-05-06 Griffith Peter H. Officer A-Award A Nqso (Right to Buy) 25,334 270.44 6.85M 25,334 D ↗
2025-05-06 Graham Jonathan P Officer A-Award A Nqso (Right to Buy) 20,554 270.44 5.56M 20,554 D ↗
2025-05-06 Gordon Murdo Officer A-Award A Common Stock 3,919 0.00 — 49,985 D ↗
2025-05-06 Drake Michael V Director A-Award A Common Stock 129 0.00 — 3,738 D ↗
2025-05-06 Busch Matthew C. Officer A-Award A Nqso (Right to Buy) 3,585 270.44 969.5K 3,585 D ↗
2025-05-06 Bradway Robert A Director / Officer A-Award A Nqso (Right to Buy) 86,042 270.44 23.27M 86,042 D ↗
2025-05-06 Bradner James E. Officer A-Award A Common Stock 3,549 0.00 — 29,753 D ↗
2025-05-02 Santos Esteban Officer F-InKind D Common Stock 621 283.78 176.2K 73,040 D ↗
2025-05-02 REESE DAVID M Officer F-InKind D Common Stock 702 283.78 199.2K 39,232 D ↗
2025-05-02 Miller Derek Officer F-InKind D Common Stock 157 283.78 44.6K 9,420 D ↗
2025-05-02 Khosla Rachna Officer F-InKind D Common Stock 110 283.78 31.2K 9,156 D ↗
2025-05-02 Grygiel Nancy A. Officer F-InKind D Common Stock 118 283.78 33.5K 7,983 D ↗
2025-05-02 Griffith Peter H. Officer F-InKind D Common Stock 665 283.78 188.7K 38,327 D ↗
2025-05-02 Graham Jonathan P Officer F-InKind D Common Stock 592 283.78 168.0K 30,337 D ↗
2025-05-02 Gordon Murdo Officer F-InKind D Common Stock 780 283.78 221.3K 46,806 D ↗
2025-05-02 Busch Matthew C. Officer F-InKind D Common Stock 37 283.78 10.5K 5,034 D ↗
2025-05-02 Bradway Robert A Director / Officer F-InKind D Common Stock 2,481 283.78 704.1K 402,540 D ↗
2025-04-30 Santos Esteban Officer F-InKind D Common Stock 759 288.56 219.0K 74,316 D ↗
2025-04-30 REESE DAVID M Officer F-InKind D Common Stock 768 288.56 221.6K 39,934 D ↗
2025-04-30 Miller Derek Officer F-InKind D Common Stock 77 288.56 22.2K 9,577 D ↗
2025-04-30 Khosla Rachna Officer F-InKind D Common Stock 74 288.56 21.4K 9,266 D ↗
2025-04-30 Grygiel Nancy A. Officer F-InKind D Common Stock 113 288.56 32.6K 8,101 D ↗
2025-04-30 Griffith Peter H. Officer F-InKind D Common Stock 640 288.56 184.7K 39,694 D ↗
2025-04-30 Graham Jonathan P Officer F-InKind D Common Stock 728 288.56 210.1K 25,922 D ↗
2025-04-30 Gordon Murdo Officer F-InKind D Common Stock 800 288.56 230.8K 47,586 D ↗
2025-04-30 Busch Matthew C. Officer F-InKind D Common Stock 18 288.56 5.2K 5,099 D ↗
2025-04-30 Bradway Robert A Director / Officer F-InKind D Common Stock 2,544 288.56 734.1K 405,021 D ↗
2025-03-17 Santos Esteban Officer F-InKind D Common Stock 3,393 313.71 1.06M 75,075 D ↗
2025-03-17 REESE DAVID M Officer F-InKind D Common Stock 3,635 313.71 1.14M 40,702 D ↗
2025-03-17 Miller Derek Officer F-InKind D Common Stock 930 313.71 291.8K 9,654 D ↗
2025-03-17 Khosla Rachna Officer F-InKind D Common Stock 489 313.71 153.4K 9,340 D ↗
2025-03-17 Grygiel Nancy A. Officer F-InKind D Common Stock 524 313.71 164.4K 8,214 D ↗
2025-03-17 Griffith Peter H. Officer F-InKind D Common Stock 3,305 313.71 1.04M 40,334 D ↗
2025-03-17 Graham Jonathan P Officer F-InKind D Common Stock 3,150 313.71 988.2K 32,266 D ↗
2025-03-17 Gordon Murdo Officer F-InKind D Common Stock 4,039 313.71 1.27M 48,386 D ↗
2025-03-17 Busch Matthew C. Officer F-InKind D Common Stock 174 313.71 54.6K 5,117 D ↗
2025-03-17 Bradway Robert A Director / Officer F-InKind D Common Stock 12,853 313.71 4.03M 587,565 D ↗
2025-03-03 Santos Esteban Officer A-Award A Common Stock 6,792 0.00 — 78,338 D ↗
2025-03-03 REESE DAVID M Officer A-Award A Common Stock 7,277 0.00 — 44,199 D ↗
2025-03-03 Miller Derek Officer A-Award A Common Stock 2,005 0.00 — 10,549 D ↗
2025-03-03 Khosla Rachna Officer A-Award A Common Stock 1,403 0.00 — 9,802 D ↗
2025-03-03 Grygiel Nancy A. Officer A-Award A Common Stock 1,503 0.00 — 8,713 D ↗
2025-03-03 Griffith Peter H. Officer A-Award A Common Stock 7,277 0.00 — 43,502 D ↗
2025-03-03 Graham Jonathan P Officer A-Award A Common Stock 6,306 0.00 — 35,293 D ↗
2025-03-03 Gordon Murdo Officer A-Award A Common Stock 8,085 0.00 — 52,271 D ↗
2025-03-03 Busch Matthew C. Officer A-Award A Common Stock 497 0.00 — 5,277 D ↗
2025-03-03 Bradway Robert A Director / Officer A-Award A Common Stock 25,734 0.00 — 599,925 D ↗
2025-02-21 REESE DAVID M Officer S-Sale D Common Stock 25,225 304.44 7.68M 36,922 D ↗
2025-02-19 Santos Esteban Officer M-Exempt D Nqso (Right to Buy) 8,711 156.35 1.36M 0 D ↗
2025-02-19 REESE DAVID M Officer M-Exempt D Nqso (Right to Buy) 8,711 156.35 1.36M 0 D ↗
2025-02-19 Miller Derek Officer M-Exempt D Nqso (Right to Buy) 1,524 156.35 238.3K 0 D ↗
2025-02-18 Miller Derek Officer S-Sale D Common Stock 500 292.56 146.3K 8,544 D ↗
2025-02-11 Gordon Murdo Officer S-Sale D Common Stock 8,771 294.79 2.59M 44,186 D ↗
2025-02-07 Graham Jonathan P Officer M-Exempt A Common Stock 25,045 156.35 3.92M 54,032 D ↗
2025-02-05 Grygiel Nancy A. Officer S-Sale D Common Stock 1,589 304.47 483.8K 7,210 D ↗
2024-12-05 Graham Jonathan P Officer G-Gift D Common Stock 6,430 0.00 — 28,903 D ↗
2024-12-02 Bradway Robert A Director / Officer G-Gift D Common Stock 96,000 0.00 — 573,855 D ↗
2024-11-05 Khosla Rachna Officer F-InKind D Common Stock 212 316.91 67.2K 8,383 D ↗
2024-11-05 Busch Matthew C. Officer F-InKind D Common Stock 189 316.91 59.9K 4,770 D ↗
2024-11-04 ISHRAK OMAR Director A-Award A Common Stock 221 0.00 — 5,081 D ↗
2024-11-04 HOLLEY CHARLES M Director A-Award A Common Stock 268 0.00 — 10,114 D ↗
2024-11-04 Drake Michael V Director A-Award A Common Stock 221 0.00 — 3,552 D ↗
2024-08-09 ISHRAK OMAR Director A-Award A Common Stock 109 0.00 — 4,833 — ↗
2024-08-09 HOLLEY CHARLES M Director A-Award A Common Stock 132 0.00 — 9,777 — ↗
2024-08-09 Drake Michael V Director A-Award A Common Stock 109 0.00 — 3,307 — ↗
2024-07-31 Grygiel Nancy A. Officer F-InKind D Common Stock 1,565 333.28 521.6K 8,771 — ↗
2024-05-31 MILES AMY E Director A-Award A Common Stock 719 0.00 — 3,927 — ↗
2024-05-31 Kullman Ellen Jamison Director A-Award A Common Stock 719 0.00 — 12,300 — ↗
2024-05-31 Klotman Mary E. Director — — — 0 0.00 — 0 — ↗
2024-05-31 Jacks Tyler Director A-Award A Common Stock 719 0.00 — 16,005 — ↗
2024-05-31 ISHRAK OMAR Director A-Award A Common Stock 719 0.00 — 4,696 — ↗
2024-05-31 HOLLEY CHARLES M Director A-Award A Common Stock 719 0.00 — 9,574 — ↗
2024-05-31 Garland Greg C. Director A-Award A Common Stock 719 0.00 — 12,374 — ↗
2024-05-31 ECKERT ROBERT Director A-Award A Common Stock 719 0.00 — 23,715 — ↗
2024-05-31 Druker Brian Director A-Award A Common Stock 719 0.00 — 6,472 — ↗
2024-05-31 Drake Michael V Director A-Award A Common Stock 719 0.00 — 3,175 — ↗
2024-05-31 Austin Wanda M Director A-Award A Common Stock 719 0.00 — 6,544 — ↗
2024-05-07 Santos Esteban Officer A-Award A Common Stock 2,997 300.30 900.0K 71,304 — ↗
2024-05-07 REESE DAVID M Officer A-Award A Common Stock 3,196 0.00 — 61,889 — ↗
2024-05-07 Miller Derek Officer A-Award A Common Stock 865 0.00 — 8,983 — ↗
2024-05-07 Khosla Rachna Officer A-Award A Common Stock 532 0.00 — 8,559 — ↗
2024-05-07 ISHRAK OMAR Director A-Award A Common Stock 117 0.00 — 3,977 — ↗
2024-05-07 HOLLEY CHARLES M Director A-Award A Common Stock 142 0.00 — 8,855 — ↗
2024-05-07 Grygiel Nancy A. Officer A-Award A Common Stock 499 0.00 — 10,300 — ↗
2024-05-07 Griffith Peter H. Officer A-Award A Nqso (Right to Buy) 20,767 300.30 6.24M 20,767 — ↗
2024-05-07 Graham Jonathan P Officer A-Award A Common Stock 2,863 0.00 — 35,186 — ↗
2024-05-07 Gordon Murdo Officer A-Award A Common Stock 3,529 0.00 — 52,674 — ↗
2024-05-07 Drake Michael V Director A-Award A Common Stock 117 0.00 — 2,456 — ↗
2024-05-07 Busch Matthew C. Officer A-Award A Nqso (Right to Buy) 2,163 300.30 649.5K 2,163 — ↗
2024-05-07 Bradway Robert A Director / Officer A-Award A Common Stock 11,988 0.00 — 669,269 — ↗
2024-05-07 Bradner James E. Officer A-Award A Nqso (Right to Buy) 18,603 300.30 5.59M 18,603 — ↗
2024-05-05 Santos Esteban Officer F-InKind D Common Stock 617 311.29 192.1K 68,307 — ↗
2024-05-05 REESE DAVID M Officer F-InKind D Common Stock 633 311.29 197.0K 58,693 — ↗
2024-05-05 Miller Derek Officer F-InKind D Common Stock 78 311.29 24.3K 8,118 — ↗
2024-05-05 Khosla Rachna Officer F-InKind D Common Stock 41 311.29 12.8K 8,027 — ↗
2024-05-05 Grygiel Nancy A. Officer F-InKind D Common Stock 82 311.29 25.5K 9,801 — ↗
2024-05-05 Griffith Peter H. Officer F-InKind D Common Stock 648 311.29 201.7K 32,777 — ↗
2024-05-05 Graham Jonathan P Officer F-InKind D Common Stock 632 311.29 196.7K 32,323 — ↗
2024-05-05 Gordon Murdo Officer F-InKind D Common Stock 665 311.29 207.0K 49,145 — ↗
2024-05-05 Busch Matthew C. Officer F-InKind D Common Stock 27 311.29 8.4K 4,599 — ↗
2024-05-05 Bradway Robert A Director / Officer F-InKind D Common Stock 2,220 311.29 691.1K 657,281 — ↗
2024-05-03 Grygiel Nancy A. Officer S-Sale D Common Stock 2,117 313.09 662.8K 9,883 — ↗
2024-05-02 Santos Esteban Officer F-InKind D Common Stock 606 277.37 168.1K 68,924 — ↗
2024-05-02 REESE DAVID M Officer F-InKind D Common Stock 650 277.37 180.3K 59,326 — ↗
2024-05-02 Miller Derek Officer F-InKind D Common Stock 152 277.37 42.2K 8,196 — ↗
2024-05-02 Khosla Rachna Officer F-InKind D Common Stock 74 277.37 20.5K 8,068 — ↗
2024-05-02 Grygiel Nancy A. Officer F-InKind D Common Stock 114 277.37 31.6K 12,000 — ↗
2024-05-02 Griffith Peter H. Officer F-InKind D Common Stock 682 277.37 189.2K 33,425 — ↗
2024-05-02 Graham Jonathan P Officer F-InKind D Common Stock 591 277.37 163.9K 32,955 — ↗
2024-05-02 Gordon Murdo Officer F-InKind D Common Stock 758 277.37 210.2K 49,810 — ↗
2024-05-02 Busch Matthew C. Officer — D Nqso (Right to Buy) 1,753 230.92 404.8K 0 — ↗
2024-05-02 Bradway Robert A Director / Officer F-InKind D Common Stock 2,294 277.37 636.3K 659,501 — ↗
2024-04-30 Santos Esteban Officer F-InKind D Common Stock 683 276.38 188.8K 69,530 — ↗
2024-04-30 REESE DAVID M Officer F-InKind D Common Stock 690 276.38 190.7K 59,976 — ↗
2024-04-30 Miller Derek Officer F-InKind D Common Stock 71 276.38 19.6K 8,348 — ↗
2024-04-30 Khosla Rachna Officer F-InKind D Common Stock 48 276.38 13.3K 8,142 — ↗
2024-04-30 Grygiel Nancy A. Officer F-InKind D Common Stock 106 276.38 29.3K 12,114 — ↗
2024-04-30 Griffith Peter H. Officer F-InKind D Common Stock 603 276.38 166.7K 34,107 — ↗
2024-04-30 Graham Jonathan P Officer F-InKind D Common Stock 686 276.38 189.6K 33,546 — ↗
2024-04-30 Gordon Murdo Officer F-InKind D Common Stock 753 276.38 208.1K 50,568 — ↗
2024-04-30 Busch Matthew C. Officer F-InKind D Common Stock 17 276.38 4.7K 4,653 — ↗
2024-04-30 Bradway Robert A Director / Officer F-InKind D Common Stock 2,282 276.38 630.7K 661,795 — ↗
2024-03-18 Santos Esteban Officer F-InKind D Common Stock 6,137 268.87 1.65M 70,213 — ↗
2024-03-18 REESE DAVID M Officer F-InKind D Common Stock 6,202 268.87 1.67M 60,666 — ↗
2024-03-18 Miller Derek Officer F-InKind D Common Stock 475 268.87 127.7K 8,419 — ↗
2024-03-18 Khosla Rachna Officer F-InKind D Common Stock 438 268.87 117.8K 8,190 — ↗
2024-03-18 Grygiel Nancy A. Officer F-InKind D Common Stock 703 268.87 189.0K 12,220 — ↗
2024-03-18 Griffith Peter H. Officer F-InKind D Common Stock 5,168 268.87 1.39M 34,710 — ↗
2024-03-18 Graham Jonathan P Officer F-InKind D Common Stock 5,879 268.87 1.58M 34,232 — ↗
2024-03-18 Gordon Murdo Officer F-InKind D Common Stock 6,461 268.87 1.74M 51,321 — ↗
2024-03-18 Busch Matthew C. Officer F-InKind D Common Stock 146 268.87 39.3K 4,670 — ↗
2024-03-18 Bradway Robert A Director / Officer F-InKind D Common Stock 20,560 268.87 5.53M 664,077 — ↗
2024-03-06 Santos Esteban Officer A-Award A Common Stock 12,278 0.00 — 76,125 — ↗
2024-03-06 REESE DAVID M Officer A-Award A Common Stock 12,407 0.00 — 66,653 — ↗
2024-03-06 Miller Derek Officer A-Award A Common Stock 1,311 0.00 — 8,863 — ↗
2024-03-06 Khosla Rachna Officer A-Award A Common Stock 1,256 0.00 — 8,597 — ↗
2024-03-06 Grygiel Nancy A. Officer A-Award A Common Stock 1,954 0.00 — 12,866 — ↗
2024-03-06 Griffith Peter H. Officer A-Award A Common Stock 10,338 0.00 — 39,250 — ↗
2024-03-06 Graham Jonathan P Officer A-Award A Common Stock 11,760 0.00 — 39,925 — ↗
2024-03-06 Gordon Murdo Officer A-Award A Common Stock 12,924 0.00 — 57,569 — ↗
2024-03-06 Busch Matthew C. Officer A-Award A Common Stock 418 0.00 — 4,799 — ↗
2024-03-06 Bradway Robert A Director / Officer A-Award A Common Stock 41,133 0.00 — 683,910 — ↗
2024-02-09 Bradner James E. Officer A-Award A Common Stock 13,806 0.00 — 22,393 — ↗

Executive team

Top executives
EBIT / Employee
381.3K
Shares Outstanding
539.69M

Executive compensation

Executive compensation (annual)
# Year ⇅ Executive ⇅ Salary ⇅ Bonus Stock award ⇅ Option award Incentive Other Total ⇅ % Stock-
based ⇅		 Filing
1 2025 Robert A. Bradway Chief Executive Officer and President 1.93M — 12.60M 5.40M 3.91M 861.1K 24.69M 72.89% ↗
2 2025 James E. Bradner Executive Vice President, Research and Development 1.24M 500.0K 3.36M 1.44M 1.68M 426.5K 8.64M 55.55% ↗
3 2025 Peter H. Griffith Executive Vice President and Chief Financial Officer 1.22M — 3.71M 1.59M 1.65M 435.2K 8.61M 61.55% ↗
4 2025 Murdo Gordon Executive Vice President, Global Commercial Operations 1.23M — 3.71M 1.59M 1.67M 322.6K 8.52M 62.18% ↗
5 2025 David M. Reese Executive Vice President and Chief Technology Officer 1.31M — 3.36M 1.44M 1.77M 415.8K 8.29M 57.90% ↗
6 2024 Robert A. Bradway Chief Executive Officer and President 1.87M — 12.60M 5.40M 3.85M 714.3K 24.43M 73.68% ↗
7 2024 James E. Bradner Executive Vice President, Research and Development 1.21M 1.02M 9.53M 1.29M 1.66M 198.9K 14.91M 72.54% ↗
8 2024 Murdo Gordon Executive Vice President, Global Commercial Operations 1.20M — 3.71M 1.59M 1.64M 334.8K 8.47M 62.54% ↗
9 2024 David M. Reese Executive Vice President, and Chief Technology Officer 1.27M — 3.36M 1.44M 1.74M 318.6K 8.13M 59.06% ↗
10 2024 David M. Reese Executive Vice President and Chief Technology Officer 1.27M — 3.36M 1.44M 1.74M 318.6K 8.13M 59.06% ↗
11 2024 Peter H. Griffith Executive Vice President and Chief Financial Officer 1.13M — 3.36M 1.44M 1.56M 318.6K 7.81M 61.48% ↗
12 2023 Robert A. Bradway Chief Executive Officer and President 1.79M — 11.14M 4.77M 4.26M 680.5K 22.64M 70.27% ↗
13 2023 Murdo Gordon Executive Vice President, Global Commercial Operations 1.14M — 3.50M 1.50M 1.82M 277.5K 8.24M 60.65% ↗
14 2023 David M. Reese Executive Vice President and Chief Technology Officer 1.21M — 3.15M 1.35M 1.93M 260.9K 7.90M 56.94% ↗
15 2023 David M. Reese Executive Vice President, and Chief Technology Officer 1.21M — 3.15M 1.35M 1.93M 260.9K 7.90M 56.94% ↗
16 2023 Peter H. Griffith Executive Vice President and Chief Financial Officer 1.08M — 3.15M 1.35M 1.72M 261.6K 7.57M 59.45% ↗
17 2022 Robert A. Bradway Chief Executive Officer and President 1.72M — 11.14M 4.77M 3.12M 643.2K 21.40M 74.36% ↗
18 2022 Murdo Gordon Executive Vice President, Global Commercial Operations 1.10M — 3.50M 1.50M 1.33M 281.3K 7.72M 64.79% ↗
19 2022 David M. Reese Executive Vice President, and Chief Technology Officer 1.16M — 3.15M 1.35M 1.40M 277.5K 7.33M 61.36% ↗
20 2022 Peter H. Griffith Executive Vice President and Chief Financial Officer 1.04M — 3.15M 1.35M 1.26M 267.5K 7.07M 63.61% ↗
21 2021 Robert A. Bradway Chief Executive Officer and President 1.67M — 11.14M 4.77M 3.42M 714.8K 21.72M 73.26% ↗
22 2021 Murdo Gordon Executive Vice President, Global Commercial Operations 1.07M — 3.50M 1.50M 1.46M 286.9K 7.82M 63.93% ↗
23 2021 David M. Reese Executive Vice President, Research and Development 1.07M — 3.36M 1.44M 1.45M 271.7K 7.59M 63.27% ↗
24 2021 Esteban Santos Executive Vice President, Operations 994.2K — 3.32M 1.42M 1.35M 264.6K 7.36M 64.51% ↗
25 2021 Peter H. Griffith Executive Vice President, and Chief Financial Officer 1.01M — 2.80M 1.20M 1.38M 267.4K 6.66M 60.02% ↗
26 2020 Robert A. Bradway Chief Executive Officer and President 1.65M — 10.08M 4.32M 3.50M 589.2K 20.13M 71.53% ↗
27 2020 Murdo Gordon Executive Vice President, Global Commercial Operations 1.06M — 2.87M 1.23M 1.49M 327.8K 6.98M 58.77% ↗
28 2020 David M. Reese Executive Vice President, Research and Development 1.02M — 2.87M 1.23M 1.44M 262.7K 6.81M 60.16% ↗
29 2020 Esteban Santos Executive Vice President, Operations 978.4K — 2.80M 1.20M 1.38M 229.6K 6.59M 60.68% ↗
30 2020 Peter H. Griffith Executive Vice President, and Chief Financial Officer 998.9K — 2.80M 1.20M 1.41M 154.4K 6.57M 60.92% ↗
31 2019 Robert A. Bradway Chief Executive Officer and President 1.60M — 9.80M 4.20M 3.32M 691.2K 19.61M 71.38% ↗
32 2019 Jonathan P. Graham Executive Vice President, General Counsel and Secretary 959.1K — 3.96M 840.0K 1.22M 261.2K 7.24M 66.29% ↗
33 2019 David W. Meline Executive Vice President and Chief Financial Officer 999.0K — 2.80M 1.20M 1.38M 292.8K 6.67M 59.93% ↗
34 2019 Murdo Gordon Executive Vice President, Global Commercial Operations 1.03M — 2.80M 1.20M 1.42M 212.5K 6.66M 60.09% ↗
35 2019 David M. Reese Executive Vice President, Research and Development 974.4K — 2.80M 1.20M 1.35M 215.8K 6.54M 61.18% ↗
36 2018 Robert A. Bradway Chief Executive Officer and President 1.57M — 8.75M 3.75M 3.90M 591.5K 18.56M 67.37% ↗
37 2018 Murdo Gordon Executive Vice President, Global Commercial Operations 330.8K 2.00M 9.90M — 513.0K 1.34M 14.08M 70.31% ↗
38 2018 Anthony C. Hooper Former Executive Vice President, Global Commercial Operations 1.06M — 2.80M 1.20M 1.75M 254.5K 7.07M 56.61% ↗
39 2018 David W. Meline Executive Vice President and Chief Financial Officer 977.7K — 2.80M 1.20M 1.62M 260.1K 6.86M 58.30% ↗
40 2018 Sean E. Harper Former Executive Vice President, Research and Development 977.7K — 2.80M 1.20M 1.62M 234.2K 6.83M 58.52% ↗
41 2018 Jonathan P. Graham Senior Vice President, General Counsel and Secretary 938.6K — 1.96M 840.0K 1.40M 204.9K 5.35M 52.38% ↗
42 2018 Jonathan P. Graham Executive Vice President, General Counsel and Secretary 938.6K — 1.96M 840.0K 1.40M 204.9K 5.35M 52.38% ↗
43 2018 David M. Reese Executive Vice President, Research and Development 697.5K 300.0K 3.03M 270.0K 913.0K 129.0K 5.34M 61.80% ↗
44 2017 Robert A. Bradway Chairman of the Board, Chief Executive Officer and President 1.56M — 8.40M 3.60M 2.68M 661.0K 16.90M 71.01% ↗
45 2017 Robert A. Bradway Chief Executive Officer and President 1.56M — 8.40M 3.60M 2.68M 661.0K 16.90M 71.01% ↗
46 2017 Anthony C. Hooper Former Executive Vice President, Global Commercial Operations 1.05M — 2.80M 1.20M 1.21M 295.5K 6.55M 61.04% ↗
47 2017 Anthony C. Hooper Executive Vice President, Global Commercial Operations 1.05M — 2.80M 1.20M 1.21M 295.5K 6.55M 61.04% ↗
48 2017 Sean E. Harper Former Executive Vice President, Research and Development 970.8K — 2.59M 1.11M 1.12M 269.7K 6.06M 61.09% ↗
49 2017 Sean E. Harper Executive Vice President, Research and Development 970.8K — 2.59M 1.11M 1.12M 269.7K 6.06M 61.09% ↗
50 2017 David W. Meline Executive Vice President and Chief Financial Officer 970.8K — 2.45M 1.05M 1.12M 271.7K 5.86M 59.74% ↗
51 2017 Jonathan P. Graham Senior Vice President, General Counsel and Secretary 932.6K — 1.75M 750.0K 858.0K 231.7K 4.52M 55.28% ↗
52 2017 Jonathan P. Graham Executive Vice President, General Counsel and Secretary 932.6K — 1.75M 750.0K 858.0K 231.7K 4.52M 55.28% ↗
53 2016 Robert A. Bradway Chairman of the Board, Chief Executive Officer and President 1.53M — 7.70M 3.30M 3.65M 668.6K 16.85M 65.28% ↗
54 2016 Anthony C. Hooper Executive Vice President, Global Commercial Operations 1.03M — 2.80M 1.20M 1.64M 294.5K 6.97M 57.43% ↗
55 2016 Jonathan P. Graham Senior Vice President, General Counsel and Secretary 916.8K 1.00M 1.61M 690.0K 1.17M 1.04M 6.42M 35.82% ↗
56 2016 David W. Meline Executive Vice President and Chief Financial Officer 946.7K — 2.45M 1.05M 1.50M 268.8K 6.22M 56.28% ↗
57 2016 Sean E. Harper Executive Vice President, Research and Development 946.2K — 2.45M 1.05M 1.50M 264.9K 6.21M 56.33% ↗
58 2015 Robert A. Bradway Chairman of the Board, Chief Executive Officer and President 1.51M — 10.20M — 3.84M 551.0K 16.10M 63.36% ↗
59 2015 Jonathan P. Graham Senior Vice President, General Counsel and Secretary 424.5K 1.43M 8.60M — 151.8K 2.18M 12.78M 67.28% ↗
60 2015 David W. Meline Executive Vice President and Chief Financial Officer 903.5K 1.00M 3.00M — 1.48M 207.4K 6.59M 45.50% ↗
61 2015 Anthony C. Hooper Executive Vice President, Global Commercial Operations 1.01M — 3.50M — 1.65M 260.2K 6.41M 54.56% ↗
62 2015 Sean E. Harper Executive Vice President, Research and Development 899.9K — 3.00M — 1.48M 232.1K 5.61M 53.49% ↗
63 2014 Robert A. Bradway Chairman of the Board, Chief Executive Officer and President 1.51M — 9.00M — 2.87M 589.0K 13.96M 64.46% ↗
64 2014 David W. Meline Executive Vice President and Chief Financial Officer 408.5K 1.00M 6.80M — 481.0K 1.91M 10.60M 64.15% ↗
65 2014 Sean E. Harper Executive Vice President, Research and Development Michael A. Kelly Former Acting Chief Financial Officer and Vice President, Global Business Services Jonathan M. Peacock Former Executive Vice President and Chief Financial Officer 428.1K — — — — 7.47M 7.90M 0.00% ↗
66 2014 Anthony C. Hooper Executive Vice President, Global Commercial Operations 1.01M — 3.00M — 1.33M 291.3K 5.62M 53.36% ↗
67 2014 David W. Meline Executive Vice President and Chief Financial Officer Sean E. Harper Executive Vice President, Research and Development 899.9K — 3.00M — 1.19M 259.8K 5.35M 56.12% ↗
68 2014 Sean E. Harper Executive Vice President, Research and Development 899.9K — 3.00M — 1.19M 259.8K 5.35M 56.12% ↗
69 2013 Robert A. Bradway Chairman of the Board, Chief Executive Officer and President 1.49M — 8.00M — 3.60M 561.1K 13.65M 58.61% ↗
70 2013 Anthony C. Hooper Executive Vice President, Global Commercial Operations 1.00M — 3.20M — 1.68M 300.8K 6.18M 51.78% ↗
71 2013 Sean E. Harper Executive Vice President, Research and Development Michael A. Kelly Former Acting Chief Financial Officer and Vice President, Global Business Services Jonathan M. Peacock Former Executive Vice President and Chief Financial Officer 904.9K — 3.20M — 1.52M 267.0K 5.89M 54.36% ↗
72 2013 David W. Meline Executive Vice President and Chief Financial Officer Sean E. Harper Executive Vice President, Research and Development 896.5K — 3.20M — 1.50M 265.2K 5.86M 54.58% ↗
73 2013 Jonathan M. Peacock Executive Vice President and Chief Financial Officer Madhavan Balachandran Executive Vice President, Operations 762.5K 330.0K 3.20M — 1.27M 203.4K 5.77M 55.47% ↗
74 2012 Robert A. Bradway Chairman of the Board, Chief Executive Officer and President 1.26M — 8.57M — 3.32M 420.1K 13.57M 63.17% ↗
75 2012 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.81M — 3.66M — 2.31M 1.36M 9.13M 40.06% ↗
76 2012 Anthony C. Hooper Executive Vice President, Global Commercial Operations 976.2K — 5.30M — 1.80M 518.1K 8.59M 61.69% ↗
77 2012 Anthony C. Hooper Executive Vice President, Global Commercial Operations 976.2K — 5.30M — 1.80M 518.1K 8.59M 61.69% ↗
78 2012 David J. Scott 845.9K — 3.91M — 1.38M 225.7K 6.37M 61.44% ↗
79 2012 Fabrizio Bonanni Executive Vice President, Operations 866.3K — 3.54M — 1.59M 346.5K 6.35M 55.81% ↗
80 2012 Sean E. Harper Executive Vice President, Research and Development Michael A. Kelly Former Acting Chief Financial Officer and Vice President, Global Business Services Jonathan M. Peacock Former Executive Vice President and Chief Financial Officer 878.9K — 3.54M — 1.62M 240.6K 6.28M 56.44% ↗
81 2012 Sean E. Harper Executive Vice President, Research and Development Michael A. Kelly Former Acting Chief Financial Officer and Vice President, Global Business Services Jonathan M. Peacock Former Executive Vice President and Chief Financial Officer 878.9K — 3.54M — 1.62M 240.6K 6.28M 56.44% ↗
82 2012 David W. Meline Executive Vice President and Chief Financial Officer Sean E. Harper Executive Vice President, Research and Development 835.0K — 3.54M — 1.54M 176.8K 6.09M 58.18% ↗
83 2012 David W. Meline Executive Vice President and Chief Financial Officer Sean E. Harper Executive Vice President, Research and Development 835.0K — 3.54M — 1.54M 176.8K 6.09M 58.18% ↗
84 2011 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.79M — 8.99M 2.38M 4.88M 800.4K 18.85M 60.35% ↗
85 2011 Anthony C. Hooper Executive Vice President, Global Commercial Operations 171.7K 3.05M 8.46M — 196.0K 174.8K 12.06M 70.20% ↗
86 2011 Anthony C. Hooper Executive Vice President, Global Commercial Operations 171.7K 3.05M 8.46M — 196.0K 174.8K 12.06M 70.20% ↗
87 2011 Robert A. Bradway Chairman of the Board, Chief Executive Officer and President 1.02M — 3.15M 833.9K 1.86M 259.5K 7.12M 55.88% ↗
88 2011 Roger M. Perlmutter Executive Vice President, Research and Development 981.8K — 2.36M 625.4K 1.43M 268.5K 5.77M 51.82% ↗
89 2011 Jonathan M. Peacock Executive Vice President and Chief Financial Officer 833.8K — 2.36M 625.4K 1.21M 245.2K 5.28M 56.62% ↗
90 2010 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.75M — 8.31M 6.69M 3.64M 756.9K 21.14M 70.95% ↗
91 2010 Jonathan M. Peacock Executive Vice President and Chief Financial Officer 270.8K 1.00M 5.73M 3.31M 267.0K 371.9K 10.95M 82.56% ↗
92 2010 Jonathan M. Peacock Executive Vice President and Chief Financial Officer 270.8K 1.00M 5.73M 3.31M 267.0K 371.9K 10.95M 82.56% ↗
93 2010 Fabrizio Bonanni Executive Vice President, Operations 820.0K — 4.53M 1.76M 910.0K 206.5K 8.23M 76.47% ↗
94 2010 Robert A. Bradway Executive Vice President and Chief Financial Officer 971.2K — 2.54M 2.67M 1.34M 251.2K 7.77M 67.03% ↗
95 2010 George J. Morrow Executive Vice President, Global Commercial Operations 1.02M — 2.19M 1.76M 1.13M 256.1K 6.48M 61.07% ↗
96 2010 Roger M. Perlmutter Executive Vice President, Research and Development 958.9K — 2.19M 1.76M 1.07M 270.8K 6.31M 62.67% ↗
97 2010 Michael A. Kelly 475.1K — 1.70M 193.3K 262.0K 1.21M 3.84M 49.30% ↗
98 2009 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.68M — 4.42M 4.66M 3.79M 791.7K 15.35M 59.18% ↗
99 2009 George J. Morrow Executive Vice President, Global Commercial Operations 991.1K — 1.44M 1.53M 1.20M 242.8K 5.67M 52.42% ↗
100 2009 Roger M. Perlmutter Executive Vice President, Research and Development 934.2K — 1.44M 1.53M 1.13M 267.0K 5.34M 55.67% ↗
101 2009 Robert A. Bradway Executive Vice President and Chief Financial Officer 883.1K — 1.44M 1.53M 1.06M 224.9K 5.14M 57.84% ↗
102 2009 Fabrizio Bonanni Executive Vice President, Operations 795.0K — 1.44M 1.53M 955.0K 208.6K 4.93M 60.30% ↗
103 2008 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.56M — 4.96M 3.58M 3.88M 530.7K 14.51M 58.88% ↗
104 2008 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.56M — 4.25M 3.56M 3.88M 530.7K 13.78M 56.70% ↗
105 2008 George J. Morrow Executive Vice President, Global Commercial Operations 970.4K — 1.68M 1.33M 1.29M 179.1K 5.56M 54.06% ↗
106 2008 Roger M. Perlmutter Executive Vice President, Research and Development 915.0K — 1.68M 1.33M 1.22M 183.4K 5.34M 56.38% ↗
107 2008 George J. Morrow Executive Vice President, Global Commercial Operations 970.4K — 1.39M 1.17M 1.29M 179.1K 5.11M 50.06% ↗
108 2008 Roger M. Perlmutter Executive Vice President, Research and Development 915.0K — 1.39M 1.17M 1.22M 183.4K 4.89M 52.34% ↗
109 2008 Robert A. Bradway Executive Vice President and Chief Financial Officer 797.7K — 1.39M 1.17M 1.20M 175.3K 4.73M 54.08% ↗
110 2008 Fabrizio Bonanni Executive Vice President, Operations 738.8K — 1.39M 1.17M 1.10M 146.9K 4.55M 56.31% ↗
111 2007 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.55M — 5.91M 10.03M 1.53M 894.2K 19.91M 80.06% ↗
112 2007 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.55M — 5.57M 3.70M 1.53M 894.2K 13.25M 70.02% ↗
113 2007 Roger M. Perlmutter Executive Vice President, Research and Development 908.4K — 1.86M 1.23M 605.0K 1.56M 6.17M 50.11% ↗
114 2007 George J. Morrow Executive Vice President, Global Commercial Operations 961.9K — 1.86M 1.23M 640.0K 278.3K 5.06M 61.08% ↗
115 2007 Robert A. Bradway Executive Vice President and Chief Financial Officer 664.3K — 1.86M 1.23M 545.0K 446.1K 4.75M 65.12% ↗
116 2007 Roger M. Perlmutter Executive Vice President, Research and Development 908.4K — 203.6K 1.43M 605.0K 1.56M 4.71M 34.70% ↗
117 2007 Fabrizio Bonanni Executive Vice President, Operations 601.5K — 1.24M 1.37M 550.0K 159.2K 3.93M 66.62% ↗
118 2007 George J. Morrow Executive Vice President, Global Commercial Operations 961.9K — 203.6K 1.43M 640.0K 278.3K 3.61M 45.36% ↗
119 2007 Fabrizio Bonanni Executive Vice President, Operations 601.5K — 787.1K 1.05M 550.0K 159.2K 3.15M 58.35% ↗
120 2007 Robert A. Bradway Executive Vice President and Chief Financial Officer 664.3K — 611.4K 400.4K 545.0K 446.1K 2.67M 37.93% ↗
121 2006 Kevin W. Sharer Chairman of the Board, Chief Executive Officer and President 1.48M — 10.41M 6.70M 4.53M 956.8K 24.08M 71.07% ↗
122 2006 Roger M. Perlmutter Executive Vice President, Research and Development 883.8K 200.0K 3.47M 2.04M 1.45M 2.02M 10.06M 54.77% ↗
123 2006 George J. Morrow Executive Vice President, Global Commercial Operations 928.6K 200.0K 3.47M 2.04M 1.52M 499.2K 8.77M 62.85% ↗
124 2006 Dennis M. Fenton Executive Vice President, Operations 849.3K — 3.81M 2.08M 1.30M 239.5K 8.27M 71.17% ↗
125 2006 Richard D. Nanula Executive Vice President and Chief Financial Officer 812.3K — 3.69M 2.04M 1.24M 230.0K 8.01M 71.50% ↗
126 2005 Kevin W. Sharer, Chairman of the Board, Chief Executive Officer 1.39M 4.50M — 225.0K — 494.7K 6.39M 3.52% ↗
127 2005 George J. Morrow, Executive Vice President, Global Commercial 887.4K 1.80M — 75.0K — 3.63M 6.31M 1.19% ↗
128 2005 Roger M. Perlmutter, Executive Vice President, Research and Development 846.1K 1.50M — 75.0K — 1.81M 4.16M 1.80% ↗
129 2005 Dennis M. Fenton, Executive Vice President, Operations 814.4K 1.20M — 75.0K — 191.9K 2.21M 3.40% ↗
130 2005 Richard D. Nanula, Executive Vice President and Chief Financial Officer 766.3K 1.21M — 75.0K — 175.6K 2.15M 3.49% ↗
131 2004 George J. Morrow, Executive Vice President, Global Commercial 823.8K 1.70M — 75.0K — 3.41M 5.93M 1.26% ↗
132 2004 Kevin W. Sharer, Chairman of the Board, Chief Executive Officer 1.30M 3.66M — 225.0K — 375.4K 5.34M 4.21% ↗
133 2004 Roger M. Perlmutter, Executive Vice President, Research and Development 794.4K 1.46M — 75.0K — 1.72M 3.97M 1.89% ↗
134 2004 Dennis M. Fenton, Executive Vice President, Operations 767.8K 1.21M 1.26M 75.0K — 183.4K 3.42M 38.97% ↗
135 2004 Dennis M. Fenton, Executive Vice President, Operations and Chief 767.8K 1.21M 1.26M — — 181.5K 3.42M 36.80% ↗
136 2004 Richard D. Nanula, Executive Vice President and Chief Financial Officer 695.4K 1.10M — 75.0K — 163.5K 1.95M 3.84% ↗
137 2003 George J. Morrow, Executive Vice President, Global Commercial 756.0K 1.39M — 150.0K — 3.17M 5.32M 2.82% ↗
138 2003 Kevin W. Sharer, Chairman of the Board, Chief Executive Officer 1.10M 2.48M — 450.0K — 235.7K 3.81M 11.81% ↗
139 2003 Roger M. Perlmutter, Executive Vice President, Research and Development 737.3K 1.37M — 150.0K — 1.59M 3.70M 4.06% ↗
140 2003 Dennis M. Fenton, Executive Vice President, Operations and Corporate 726.8K 1.15M — — — 344.5K 2.22M 0.00% ↗
141 2003 Dennis M. Fenton, Executive Vice President, Operations and Chief 726.8K 1.15M — — — 344.5K 2.22M 0.00% ↗
142 2003 Dennis M. Fenton, Executive Vice President, Operations 726.8K 1.15M — 150.0K — 186.5K 2.06M 7.29% ↗
143 2003 Richard D. Nanula, Executive Vice President, Finance, Strategy and 658.3K 1.04M — — — 188.8K 1.89M 0.00% ↗
144 2003 Richard D. Nanula, Executive Vice President and Chief Financial Officer 658.3K 1.04M — 150.0K — 130.2K 1.83M 8.20% ↗
145 2002 George J. Morrow, Executive Vice President, Global Commercial 683.3K 1.28M — — — 3.02M 4.98M 0.00% ↗
146 2002 Roger M. Perlmutter, Executive Vice President, Research and Development 683.3K 1.28M — — — 1.42M 3.37M 0.00% ↗
147 2002 Kevin W. Sharer, Chairman of the Board, Chief Executive Officer and President Executive Vice President, Research and Development Executive Vice President, Worldwide Sales and Marketing Executive Vice President, Finance, Strategy and Communications and Chief Financial Officer 980.0K 1.80M — — — 497.8K 3.28M 0.00% ↗
148 2002 Kevin W. Sharer, Chairman of the Board, Chief Executive Officer 980.0K 1.80M — — — 497.8K 3.28M 0.00% ↗
149 2002 Dennis M. Fenton, Executive Vice President, Operations and Chief 680.0K 1.07M — — — 13.2K 1.76M 0.00% ↗
150 2002 Dennis M. Fenton, Executive Vice President, Operations and Corporate 680.0K 1.07M — — — 13.2K 1.76M 0.00% ↗
151 2002 Richard D. Nanula, Executive Vice President, Finance, Strategy and 616.7K 971.3K — — — 57.3K 1.65M 0.00% ↗
152 2002 Richard D. Nanula, Executive Vice President and Chief Financial Officer 616.7K 971.3K — — — 57.3K 1.65M 0.00% ↗
153 2001 Roger M. Perlmutter, Executive Vice President, Research and Development 637.9K 1.50M 6.54M — — 1.37M 10.05M 65.09% ↗
154 2001 Richard D. Nanula, Executive Vice President, Finance, Strategy and 375.0K 315.0K 5.52M — — 25.2K 6.24M 88.54% ↗
155 2001 George J. Morrow, Executive Vice President, Global Commercial 618.3K 1.50M — — — 2.62M 4.74M 0.00% ↗
156 2001 Kevin W. Sharer, Chairman of the Board, Chief Executive Officer 933.3K 860.5K — — — 95.8K 1.89M 0.00% ↗
157 2001 Kevin W. Sharer, Chairman of the Board, Chief Executive Officer and President Executive Vice President, Research and Development Executive Vice President, Worldwide Sales and Marketing Executive Vice President, Finance, Strategy and Communications and Chief Financial Officer 933.3K 860.5K — — — 95.8K 1.89M 0.00% ↗
158 2001 Dennis M. Fenton, Executive Vice President, Operations and Corporate 652.3K 635.2K — — — 35.3K 1.32M 0.00% ↗
159 2000 Kevin W. Sharer, Chairman of the Board, Chief Executive Officer and President Executive Vice President, Research and Development Executive Vice President, Worldwide Sales and Marketing Executive Vice President, Finance, Strategy and Communications and Chief Financial Officer 810.6K 1.36M — — — 79.0K 2.25M 0.00% ↗
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-21 DEFA14A ↗
2026-04-15 DEFA14A ↗
2026-04-07 DEFA14A ↗
2026-04-07 DEF 14A ↗

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗

Executive team

NameTitleCompensationGender
Robert A. Bradway Chairman & CEO 7M male
James E. Bradner Executive Vice President of Research & Development 4M —
David Reese Executive Vice President & Chief Technology Officer 3M —
Peter H. Griffith Executive Vice President & Chief Financial Officer 3M male
Murdo Gordon Executive Vice President of Global Commercial Operations 3M male
Esteban Santos Executive Vice President of Operations 3M male
Scott Skellenger Senior Vice President & Chief Information Officer — male
Howard Y. Chang Senior Vice President of Global Research & Chief Scientific Officer — male
Matthew C. Busch Chief Accounting Officer & Vice President of Finance — male
Casey Capparelli Executive Director of Investor Relations — —
ESG Rating
B
DRUG MANUFACTURERS - GENERAL
2008
E (Environmental)
68.3 / 68.7
Company / Sector avg.
S (Social)
54.0 / 66.7
Company / Sector avg.
G (Governance)
68.1 / 67.9
Company / Sector avg.
ESG Total
63.5 / 67.7
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - GENERAL
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2026-04-07 2026-05-01 Mark Warner VA Self Sale $1,001 - $15,000 ↗
2026-04-06 2026-05-01 Mark Warner VA Joint Sale $1,001 - $15,000 ↗
2025-09-04 2025-10-03 Sheldon Whitehouse RI Self Sale (Full) $1,001 - $15,000 ↗
2025-09-04 2025-10-03 Sheldon Whitehouse RI Self Sale $1,001 - $15,000 ↗
2025-04-15 2025-05-15 Tommy Tuberville AL Joint Sale (Full) $15,001 - $50,000 ↗
2025-04-15 2025-05-15 Tommy Tuberville AL Joint Sale $15,001 - $50,000 ↗
2024-09-17 2024-10-10 Sheldon Whitehouse RI Self Sale (Partial) $1,001 - $15,000 ↗
2024-01-19 2024-02-14 Tommy Tuberville AL Joint Sale (Full) $15,001 - $50,000 ↗
2023-06-12 2023-07-17 Shelley Moore Capito WV Spouse Sale (Full) $1,001 - $15,000 ↗
2022-10-06 2022-11-10 Tommy Tuberville AL Joint Purchase $1,001 - $15,000 ↗
2022-01-12 2022-02-14 Tommy Tuberville AL Joint Purchase $1,001 - $15,000 ↗
2021-12-15 2022-01-21 Shelley Moore Capito WV Spouse Purchase $1,001 - $15,000 ↗
2020-11-05 2020-12-08 Bill Cassidy LA Spouse Sale (Full) $1,001 - $15,000 ↗
2020-04-07 2020-05-01 Kelly Loeffler GA Joint Sale (Full) $250,001 - $500,000 ↗
2020-04-07 2020-05-01 Kelly Loeffler GA Spouse Purchase $15,001 - $50,000 ↗
2020-03-09 2020-03-27 Bill Cassidy LA Spouse Sale (Partial) $1,001 - $15,000 ↗
2020-03-04 2020-05-01 Kelly Loeffler GA Spouse Sale (Full) $15,001 - $50,000 ↗
2019-02-04 2019-03-01 John Reed RI Joint Sale (Full) $1,001 - $15,000 ↗
2018-12-07 2019-08-07 Bill Cassidy LA Spouse Sale (Partial) $1,001 - $15,000 ↗
2018-04-24 2019-05-09 Shelley Moore Capito WV Spouse Purchase $1,001 - $15,000 ↗
House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2026-03-24 2026-04-22 Maria Elvira Salazar FL27 — Purchase $15,001 - $50,000 ↗
2026-02-26 2026-03-09 David Taylor OH02 — Sale $1,001 - $15,000 ↗
2026-01-29 2026-02-03 David Taylor OH02 — Sale $1,001 - $15,000 ↗
2026-01-16 2026-02-03 David Taylor OH02 — Purchase $1,001 - $15,000 ↗
2025-12-03 2025-12-08 David Taylor OH02 — Sale $1,001 - $15,000 ↗
2025-10-24 2025-10-29 Marjorie Taylor Greene GA14 — Purchase $1,001 - $15,000 ↗
2025-09-25 2025-10-22 Lisa McClain MI09 Spouse Sale (Full) $1,001 - $15,000 ↗
2025-09-11 2025-09-29 Marjorie Taylor Greene GA14 — Purchase $1,001 - $15,000 ↗
2025-06-24 2025-08-13 Lisa McClain MI09 Spouse Purchase $1,001 - $15,000 ↗
2025-06-24 2025-08-14 Lisa McClain MI09 Spouse Purchase $1,001 - $15,000 ↗
2025-06-06 2025-07-10 Cliff Bentz OR02 Spouse Purchase $1,001 - $15,000 ↗
2025-05-14 2025-05-20 Marjorie Taylor Greene GA14 — Purchase $1,001 - $15,000 ↗
2025-05-12 2025-06-23 Jefferson Shreve IN06 — Sale $15,001 - $50,000 ↗
2025-05-05 2025-05-07 Marjorie Taylor Greene GA14 — Purchase $1,001 - $15,000 ↗
2025-04-16 2025-05-12 Jared Moskowitz FL23 — Purchase $1,001 - $15,000 ↗
2025-04-11 2025-05-09 Jefferson Shreve IN06 — Purchase $15,001 - $50,000 ↗
2025-04-08 2025-05-08 Rob Bresnahan PA08 — Sale (Full) $1,001 - $15,000 ↗
2025-02-24 2025-03-09 Jefferson Shreve IN06 — Purchase $15,001 - $50,000 ↗
2025-02-11 2025-08-21 Daniel Meuser PA09 Spouse Sale $1,001 - $15,000 ↗
2025-01-06 2025-02-11 Emily Randall WA06 Spouse Sale (Full) $1,001 - $15,000 ↗
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Drug Manufacturers - General